N4 Pharma PLC 0GO-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:08 AM CEST
0.087quote price arrow up+0.004 (+4.82%)
52 week range
0.05 - 0.14

...

Loading . . .
  • Open0.087
  • Day High0.087
  • Day Low0.087
  • Prev Close0.083
  • 52 Week High0.14
  • 52 Week High Date02/12/21
  • 52 Week Low0.05
  • 52 Week Low Date02/02/21

Key Stats

  • Market Cap20.13M
  • Shares Out181.08M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.087
  • Day High0.087
  • Day Low0.087
  • Prev Close0.083
  • 52 Week High0.14
  • 52 Week High Date02/12/21
  • 52 Week Low0.05
  • 52 Week Low Date02/02/21
  • Market Cap20.13M
  • Shares Out181.08M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-8.70
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From N4 Pharma PLC

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
N4 Pharma Plc, formerly Onzima Ventures plc, is a United Kingdom-based specialist pharmaceutical company. The Company is engaged in reformulating existing drugs and vaccines to improve their performance. It operates in two divisions: generic and vaccines. Its generics division includes Sildenafil, Sartans, Aprepitant and Single dose Hepatitis B. Its vaccines include Nuvac and Nuvec. The Company is improving Sildenafil for erectile dysfunction. Sartans is a family of drugs...
John Chiplin Ph.D.
Non-Executive Chairman
Nigel Theobald
Chief Executive Officer
Address
Weston House, 1 Bradgate Park View
Derby
DE73 5UJ
United Kingdom